Suppression of Human Lymphoma Development in the Severe Combined Immune-Deficient Mouse by Imexon Therapy
- 1 February 1993
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Immunotherapy
- Vol. 13 (2), 77-83
- https://doi.org/10.1097/00002371-199302000-00001